Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED 50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.
Introduction
Drug discrimination has served as an important technique in behavioural pharmacology for at least 40 years, with applications in drug discovery, research in academia and testing for abuse liability. The characteristics of drugproduced discriminative stimuli are not fixed and invariant, but are influenced by behavioural and pharmacological variables. The dose of drug used to establish a discrimination is thought to influence both its qualitative and quantitative characteristics. Dose selection is, therefore, critically important in study design; different studies of the same drug may not use the same training dose and may therefore yield varying results. When using drugdiscrimination procedures in, for example, drug discovery or drug-abuse research, incomplete knowledge of training-dose effects can lead to incorrect assumptions about receptor mechanisms and abuse liability.
For many classes of discriminable drugs, systematic within-experiment, studies of the role of training dose have been published and these can be an invaluable guide for planning research. This article reviews such studies to identify any general principles that may emerge. Experiments of this type were published from the early 1970s onwards, the first apparently being Cameron and Appel (1973) , followed by Hirschhorn and Rosecrans (1974) and Overton (1975) . These studies covered lysergic acid diethylamide (LSD), nicotine, dissociative anaesthetics and pentobarbital, and they were soon followed by investigations with amphetamines, benzodiazepines, opioids and alcohol.
This review covers the majority of relevant studies deemed to be of adequate quality; systematic variation of training dose within a study is the key criterion for inclusion alongside other standard indicators such as peer-review publication, adequate numbers of subjects, and full descriptions of methodology. The drug-discrimination database, searched with the keyword 'training dose varied', was a major bibliographic source (Meisch et al., 2011) . Several previous articles contain useful, but less comprehensive, reviews on this subject (e.g., Järbe, 1989) . The quantitative characteristics of drug discriminations include a number of training sessions to establish a discrimination, maximum-attainable discrimination accuracy and ED 50 values when dose-response curves are determined. The ED 50 value is commonly used as a measure of subjects' sensitivity to drugs, and it is widely believed that lower training doses are associated with lower ED 50 values; the evidence for this assumption will be assessed. In addition, training dose may show an impact on qualitative aspects of a discrimination, as defined by changes in the drugs to which generalization occurs, and sensitivity to antagonists. Evidence from studies directly comparing different training doses will be used to assess support for the view that lower training doses lead to reduced pharmacological specificity of the resulting cue. A different perspective is that as training dose is reduced, the relative salience of the different stimulus elements in a complex, drug-produced stimulus changes, leading to increases in generalization to some drugs and reduced generalization to others. The concept of drug-induced discriminative stimulus complexes was discussed explicitly in seminal papers by Colpaert et al. (1976a Colpaert et al. ( , 1976b , and it underlies much later thinking in the area.
This review considers whether any general principles relating to the impact of training dose can be identified, in terms of similarities of findings across different drug classes, methodological approaches, and other variables. It is subdivided into sections covering different drug classes, with the classes studied most intensively with respect to training dose generally appearing before the classes subjected to fewer investigations. The final section aims to draw together the findings from the different drug classes.
Psychomotor stimulants Cocaine
Rodent and monkey studies using within-subjects designs revealed quantitative differences in the cocaine stimulus when fading procedures were used to establish low-dose discriminations Spealman and Bergman, 1994; Terry et al., 1994) but not when training doses were increased . ED 50 values decreased at low doses, often accompanied by decreased specificity. reported that as training dose decreased, the slope of the generalization curve decreased as well. Between-subjects studies also revealed quantitative differences; typically, sensitivity of discrimination was increased at lower doses, with lower ED 50 values Callahan et al., 1992; Kantak et al., 1995 Kantak et al., , 1999 Schechter, 1997; Costanza et al., 2001; Wilcox et al., 2001; Quinton et al., 2006) . reported steeper generalization gradients at lower doses, which mirrored within-subject comparisons in the same study. However, others have not reported variations in slope with training dose. The study of is also noteworthy because it presented direct comparisons of error rates in drug and nondrug training sessions. At certain training doses, the response after cocaine was acquired more rapidly and thus a relatively large proportion of errors occurred in nondrug sessions.
Most studies of qualitative differences between highdose and low-dose cocaine cues have used betweensubjects designs in rodents. Dopamine-releasing agents generalized fully at all training doses (Schechter, 1997; Cunningham et al., 2006; Quinton et al., 2006) .
The selective dopamine reuptake inhibitor, GBR12909, and dopamine D1 receptor agonists fully generalized at all training doses (Kantak et al., 1995) . However, competitive N-methyl-D-aspartic acid (NMDA) antagonists substituted for low but not high doses of cocaine (Kantak et al., 1995) . Apomorphine, a mixed D1/D2 agonist, substituted more fully at low cocaine doses Kantak et al., 1995) . Conversely, D2 agonists substituted to a greater extent at high doses, whereas D2 antagonists and inverse agonists shift the generalization curve rightward at both low and high doses (Costanza et al., 2001) . Together, these studies suggest a divergence of the dopaminergic substrates mediating the stimulus properties of low and high cocaine doses.
In squirrel monkeys, Spealman (1995) reported that GBR 12909 substituted for cocaine at low and high doses, selective noradrenaline-reuptake inhibitors (SNRI) substituted for the low dose only, whereas a selective serotonin (5-HT)-reuptake inhibitor and noradrenaline a1, a2 and b2 agonists did not substitute at any dose. Pretreatment with an a1 antagonist attenuated cocaine generalization at both doses and the low-dose cocaine-like effects of the noradrenaline but not the dopaminereuptake inhibitor. Pretreatment with a nonselective a2 and b antagonist did not influence cocaine generalization at any dose. Pretreatment with a low dose of an SNRI, talsupram, potentiated high-dose and low-dose cocainelike responding after GBR 12909. Together, these findings suggest that noradrenaline reuptake and a1 mechanisms play a role in the stimulus effects of cocaine. In line with this hypothesis, agents with noradrenergic activity, including cocaine analogues and modafinil, fully substitute for low but not high cocaine doses in rodents (Wilcox et al., 2001; Cunningham et al., 2006; Dopheide et al., 2007) .
Cocaine-trained subjects often generalize partially to opiate agonists; morphine produced additive effects upon drug-lever responding at a low dose of cocaine, an effect thought to be mediated by morphine-induced release of dopamine (Kantak et al., 1999) . Kappa-selective agonists shifted the low-dose cocaine generalization curve to the right but did not fully generalize with the cocaine cue, and d-selective agonists did not generalize with or alter the cocaine cue at any of the training doses used in monkeys (Spealman and Bergman, 1994) . Finally, nicotinic agonists fully substitute for both low and high cocaine doses (Cunningham et al., 2006) . Koek (1997, 1998) trained rats to discriminate high doses of cocaine from low doses and found that high cocaine doses elicited more accurate responding, that is, more correct lever selections. Administration of nonselective b-adrenoceptor antagonists, but not b1 or 5-HT 1A antagonists, together with the low dose of cocaine, switched responding from the low to the high-dose lever, suggesting a role of a b2 mechanism in the high-dose cue.
Selective serotonin (5-HT)-reuptake inhibitors and SNRIs also increased high-dose responding in combination with the low cocaine dose, indicating a role of 5-HT and noradrenaline in the stimulus effects of high cocaine doses.
In summary, the discriminative effects of cocaine are influenced both quantitatively and qualitatively by training dose. At low doses, discriminative effects are probably mediated by dopaminergic and noradrenergic systems involving D1, D2 and a2 receptors respectively. At high doses, effects at D2, b2 and 5-HT (but not 5-HT 1A ) receptors may be more important.
Amphetamines
In humans, amphetamine discrimination was readily acquired (Kollins and Rush, 1999) . Stimulus control was significantly better at higher training doses in the sense that vehicle produced more drug-lever responding in the low-dose group than in the high-dose group. However, generalization curves were shifted leftwards at lower doses. Interestingly, there were similar leftward shifts in the dose-response functions for some self-reported subjective effects including drug liking and sociability, but not for others such as euphoria or anxiety, suggesting some dissociation between the discriminative stimulus and subjective effects of amphetamine in humans.
Most studies have used between-subject designs with rodents to study quantitative differences in the stimulus properties of amphetamine as a function of training dose. Some have shown that generalization curves are steeper at low doses (Stadler et al., 2001) , whereas others have reported steeper curves at high doses (Stolerman and D'Mello, 1981) . Overall, the accuracy of discrimination was enhanced at higher doses, yet at lower doses ED 50 values were often lower, albeit nonsignificantly, indicating enhanced sensitivity, that is, an ability to discriminate smaller doses of drug from vehicle (Stolerman and D'Mello, 1981; Barrett and Steranka, 1983; Snoddy and Tessel, 1983; Sanger, 1988; Stadler et al., 2001) . For example, Stolerman and D'Mello (1981) reported increases in drug-lever responding after 0.06 mg/kg in rats trained with 0.4 mg/kg, whereas those trained at 1 mg/kg did not show increased drug-lever responding at doses of amphetamine of less than 0.5 mg/kg. Cocaine fully substituted for amphetamine, and its ED 50 was lower at low training doses (Stolerman and D'Mello, 1981; Stadler et al., 2001) . Parahydroxyamphetamine, which is highly lipophilic and thus penetrates poorly to the central nervous system, showed greater generalization at low training doses but conversely, apomorphine substituted more at higher doses (Colpaert et al., 1976c; Stolerman and D'Mello, (1981) . Gaiardi et al. (2001) found that dizocilpine, a noncompetitive NMDA antagonist, generalized more with a low dose, whereas CGP 43487, a competitive antagonist, did not.
Other findings suggest a role for noradrenergic mechanisms in the stimulus effects of low amphetamine doses. Nisoxetine, a noradrenaline reuptake inhibitor, generalized with the interoceptive effects of a low but not a high training dose of amphetamine in mice, and pretreatment with nisoxetine shifted the low-dose generalization gradient for amphetamine leftwards (Snoddy and Tessel, 1983) . In contrast, a study in rats did not report any influence of a2 antagonists upon the discriminative effects of high or low amphetamine doses (Sanger, 1988) . Thus, the differential involvement of a1 and b adrenoceptors as a function of training dose remains to be clarified in rodents.
In summary, both human and animal studies illustrate quantitative differences in the stimulus effects of high and low training doses of amphetamine. At low doses, stimulus control was weaker but subjects exhibited greater sensitivity to small doses of amphetamine. There is limited evidence for qualitative variation in the discriminative stimulus properties of low and high amphetamine doses, although suggestions that peripheral stimulation may be more important at low doses warrant further investigation.
Caffeine
Human studies demonstrate that caffeine is readily discriminated from placebo at doses as low as 10 mg and even at 1.8 mg in some individuals (Griffiths et al., 1990; Mumford et al., 1994) . These studies show that sensitivity to the stimulus effects of caffeine is positively correlated with the number and magnitude of selfreported subjective effects, indicating a functional relationship between these behavioural properties of caffeine. Findings also suggest that low caffeine doses are discriminated based on the alerting and positive mood effects.
Studies with rodents demonstrate that the interoceptive effects of caffeine vary quantitatively with training dose (Holtzman, 1986; Mumford and Holtzman, 1991; Powell et al., 1999) . At high training doses, discrimination was acquired faster and the generalization gradient shifts rightward. The stimulus properties of caffeine vary qualitatively with dose. Other stimulant drugs, including cocaine, amphetamine, methylphenidate and ephedrine substituted more fully at lower doses, as did other methylxanthines (Holtzman, 1986; Mumford and Holtzman, 1991) . The low-dose cue partially generalized to dopamine agonists and may be attenuated by anoradrenaline or dopamine antagonists, by adenosine analogues, and diverse behavioural depressants. In contrast, the high-dose caffeine cue was harder to characterize; the only agent that fully generalized was theophylline (Mumford and Holtzman, 1991) , and dopamine antagonists did not block caffeine (Powell et al., 1999) . Agents that produce anxiety-like behaviour in animals, such as Training dose in drug discrimination Stolerman et al. 417 benzodiazepine inverse agonists, and the adrenoceptor antagonist yohimbine did not generalize at high training doses. The NMDA antagonist, phencyclidine, also did not generalize.
In summary, there is a close agreement between the results of human and animal studies, which demonstrate that the caffeine cue varies quantitatively and qualitatively with training dose. At low doses, discrimination appears to be based on states of alertness or arousal mediated by adrenergic and dopaminergic systems. However, the substrates mediating discrimination at high doses remain unclear.
Opioids
A study in human subjects trained to discriminate progressively lower doses of the m-opioid agonist hydromorphone, considered together with data from animal studies on buprenorphine, indicated that the progressive reduction of the training dose most likely enhanced discrimination sensitivity (Preston and Bigelow, 1998) . A firmer conclusion was not possible, in part because doseresponse curves for hydromorphone at the different training doses were not determined. Variation in the training dose of opioids has been examined more extensively in rats and pigeons. Overton and Batta (1979) used a T-maze procedure to train rats at several doses of various opioids; the number of sessions to criterion was inversely related to training dose. Investigations using two-lever procedures showed that ED 50 values for full opioid agonists decreased at lower training doses, both in between-group studies (Shannon and Holtzman, 1979; Colpaert et al., 1980a Colpaert et al., , 1980b Koek and Slangen, 1982; Krimmer et al., 1984; Picker et al., 1990; Young et al., 1992; Picker et al., 1992; Zhang et al., 2000) and in the same rats after retraining at a lower dose . Figure 1 shows results from a classical study on fentanyl. In contrast, changes in ED 50 values were not seen after training with the k-opioid U50488 (Picker et al., 1990) , or the partial (mixed) agonists, buprenorphine (Holtzman, 1997) and nalbuphine (Walker and Young, 1993) . However, full and partial agonists do not seem to have been compared directly within a study.
Studies in rodents have also yielded evidence for qualitative changes in patterns of generalization at different training doses. Full generalization to partial agonists was apparent in rats at low training doses of the full m-agonists, morphine and fentanyl, whereas at higher training doses, there was often partial or no generalization to partial opioid agonists (Shannon and Holtzman, 1979; Picker et al., 1990; Picker et al., 1992; Young et al., 1992; Zhang et al., 2000) . Findings were similar with morphine discrimination established by taste aversion conditioning (Grabus et al., 1999) . Comparisons of generalization profiles to nonopioid compounds produced varying results, with some studies suggesting retention of specificity at low training doses (Koek and Slangen, 1982) , whereas others indicated reduced specificity (Shannon and Holtzman, 1979; Colpaert et al., 1980b; Picker et al., 1990) . Holtzman 1997 showed an increased generalization to the partial agonists pentazocine and nalbuphine in rats trained with a low dose of buprenorphine. At a high training dose of the k-agonist U50488, rats generalized to other k-agonists but not to magonists, whereas at a lower training dose, both m-agonists and k-agonists generalized, together with increased responding to nonopioid agents (Picker et al., 1990) . In contrast, Broqua et al. (1998) did not find generalization to morphine from a low training dose of U50488. In pigeons, an increased sensitivity at low training doses was seen consistently with the full and partial agonists (Gauvin and Young, 1989; Koek and Woods, 1989; Picker et al., 1993; Cook and Picker, 1998) ; in these studies, specificity was sometimes, but not always, retained.
There is also evidence for qualitative changes in opioid discrimination in pigeons as a function of training dose. Picker (1991) identified a naloxone-sensitive opioid component in discrimination of low doses of N-allylnormetazocine [(-)-NANM, SKF-10047], whereas a large dose was predominantly phencyclidine-like. Interestingly, by comparing data for different training doses of fentanyl, Picker et al. (1993) were able to identify three groups of opioids, that is, (a) those substances that Log-probit plot of dose-response curves in different groups of rats trained to discriminate fentanyl from saline at doses of 0.005, 0.01, 0.02 or 0.04 mg/kg in a two-lever, operant conditioning procedure with a fixed ratio 10 schedule of food reinforcement. The typical leftward shifts of the dose-response curve at lower training doses can be seen, as well as flattening of dose-response curves as the training dose approached levels that were too low to be discriminable (reproduced from Colpaert et al., 1980b , Adapted with permission from Elsevier).
generalized fully at both doses, with steep dose-response curves and few interanimal differences; (b) those generalizing fully with low training doses but to a slightly lesser extent with a large dose, with shallower slopes and marked interanimal differences; and (c) those generalizing with the low dose only, with shallow dose-response curves, large interanimal differences, and the ability to antagonize a high training dose of fentanyl. These different response patterns correlated with differences in intrinsic efficacy at m-opioid receptors (Picker et al., 1993) . Similarly, when subjects were trained on a low dose of morphine, an increased generalization to cyclazocine and (-)-NANM emerged (Cook and Picker, 1998 ). An absence of full generalization from a high training dose of fentanyl to meperidine and profadol may have been a consequence of rate-decreasing effects of these substances mediated through nonopioid mechanisms (Picker et al., 1994) . Quantification of antagonism has also been valuable in this area; for example, naltrexone antagonized both low and high doses of fentanyl with PA 2 values of 7.6 and 7.5, respectively, suggesting that similar receptors were involved (Zhang et al., 2000) .
Studies of dose versus dose discrimination also shed light on the role of training dose. Partial m-agonists and kagonists typically generalized with a low training dose in rats trained with fentanyl or bremazocine but antagonized a higher training dose (Colpaert and Janssen, 1986; Smith and Picker, 1995) . Results compatible with those of the preceding studies were obtained in elegant threeresponse procedures in pigeons and humans trained to discriminate between saline and each of two doses of a m-agonist (Vanecek and Young, 1995; Jones et al., 1999) .
To summarize, quantitative changes associated with training dose were apparent, with leftward shifts in dose-response curves seen at low doses in almost all studies of training with full m-opioid agonists in rats and pigeons and with a partial agonist in pigeons. Results were inconsistent for partial-agonist training in rats, and a shift was not seen in one study involving training with a k-opioid in pigeons. Qualitative changes were also seen in both species, consisting primarily of an increased generalization to partial agonists when the training dose of a full agonist was low. However, specificity of stimulus control was not always preserved at low intensities of opioid receptor stimulation.
Alcohol
Ethanol is the most studied form of alcohol in drugdiscrimination procedures. The effect of ethanol training dose on quantitative and qualitative aspects of ethanoldiscriminative stimulus effects has been well documented both within and between subjects. Between subjects, the acquisition of ethanol discrimination consistently required fewer training sessions at higher doses in both rats (Overton, 1974; York, 1978; Grant and Colombo, 1993a; Colombo et al., 1995; Green et al., 1997; Szeliga and Grant, 1998; Grant, 1998, 1999; Bowen et al., 1999a; Quertemont and Grant, 2002; Quertemont et al., 2003) and monkeys . The widest range of training doses studied under identical conditions was with a T-maze by Overton (1974) and encompassed 0.06-2.5 g/kg, requiring 500 and 20 trials, respectively (Fig. 2) . A very similar effect of dose range (0.33-0.99 g/kg) on trials (100-20) was found with a two-lever operant procedure (York, 1978) . Typically, there was a direct relationship between ethanol training dose (range, 0.8-2.0 g/kg) and the ED 50 of ethanol substitution, although the differences were generally not statistically significant (Colombo et al., 1995; Grant et al., 1997; Grant, 1998, 1999; Quertemont and Grant 2002; Quertemont et al., 2003; Ginsberg and Lamb, 2005) . Furthermore, in the studies cited above, the ethanol training dose generally did not have a significant effect on rates of responding, except with training doses of more than 2.25 g/kg (Overton, 1974) .
Ethanol is a unique drug for examining the qualitative effects of training dose because the range of compounds that generalize to alcohol encompasses many pharmacological classes, and this lower specificity is not necessarily restricted to a lower training dose. A composite of most discrimination outcomes shows that g-aminobutyric acid type A (GABA A )-positive modulators, NMDA antagonists and 5-HT agonists all substitute for ethanol (reviewed in Grant, 1999) . However, direct GABA A agonists (Grant Relationship between training doses and sessions to a criterion of discrimination performance for pentobarbital, phenobarbital and ethanol administered intraperitoneally at the doses shown for rats in a T-maze shock-escape task. Criterion performance was eight correct first-trial choices during 10 consecutive training sessions ( Fig. 1 from Overton, 1977 , reproduced with kind permission of Springer Science and Business Media).
Training dose in drug discrimination Stolerman et al. 419 and Colombo, 1993a) , neuroactive steroids with activity at NMDA receptors (Bowen et al., 1999a (Bowen et al., , 1999b , taurine (Quertemont et al., 2003) , acetaldehyde (Quertemont and Grant, 2002) , morphine (Grant and Colombo, 1993c, Szeliga and , voltage-sensitive calcium antagonists (Green and Grant, 1999; Green-Jordan and Grant, 2000) and g-hydroxybutyric acid (GHB; Helms et al., 2008b) fail to generalize across a range of training doses of ethanol. Thus, although ethanol is a mixed discriminative stimulus, it still retains pharmacological specificity, and this specificity is not linear with the training dose.
The drugs that substitute for lower but not higher ethanol training doses are barbiturates (Grant and Colombo, 1993a; York, 1978) , neuroactive steroids (Bowen et al., 1999a (Bowen et al., , 1999b , g-hydroxybutyrate (Colombo et al., 1995) and 5-HT agonists (Grant and Colombo, 1993b; Grant et al., 1997; Green and Grant, 1998) in rats, and benzodiazepines Helms et al., 2008b) in monkeys. However, this was not the case for the GABA A -neuroactive steroid anaesthetic alphaxalone, which showed substitution at both lower and higher training doses in rats (Ginsberg and Lamb, 2005) . In contrast to this substitution pattern, NMDA antagonists appeared to generalize more at higher than lower training doses in rats (Grant and Colombo, 1993a) and monkeys (Vivian et al., 2002) but again, with some exceptions (Green and Grant, 1998) .
Ethanol training dose also affects the ED 50 of substitution differentially, with a lower ethanol training dose resulting in lower ED 50 for pentobarbital (Grant and Colombo, 1993c; Green and Grant, 1998) ; the 5-HT agonists mCPP, trifluoromethylphenylpiperazine (TFMPP) and Ru24969 (Grant and Colombo, 1993b; Grant et al., 1997) ; and the neuroactive steroids alphaxalone (Ginsberg and Lamb, 2005) and allopregnanolone (Bowen et al., 1999a) . Similar to these findings in rats, monkeys also exhibited lower ED 50 values for pentobarbital and allopregnanolone, using 1.0 g/kg compared with 2.0 g/kg of ethanol as a training dose , Helms et al., 2008a . In contrast to the GABA Apositive modulators, higher ED 50 doses were associated with 1.0 g/kg of ethanol training compared with 2.0 g/kg of ethanol training in the substitution of the NMDA antagonists ( + )3-(2-carboxypiperazin-4-propyl)-1-propenyl-1-phosphonic acid (CPP) and dizocilpine; this was also the case for the dissociative anaesthetics ketamine and phencyclidine in rats (Grant and Colombo, 1993a; Green et al., 1997) , but not in monkeys (Vivian et al., 2002) . In general, both qualitative and quantitative aspects of stimulus generalization suggested a differential effect of ethanol training dose, with lower training dose cues mediated by positive GABA A and 5-HT 1B/2C modulation and higher training dose cues more sensitive to the effects of dissociative anaesthetics.
Within-subject differences in the training dose of ethanol have been primarily assessed in rats trained to discriminate ethanol in a three-lever 'dose versus dose versus no drug' procedure, in which neuroactive steroids that are GABA A -positive modulators show greater qualitative and quantitative substitutions for 1.0 g/kg of ethanol compared with 2.0 g/kg of ethanol (Bowen et al., 1999b) . Another approach to within-subject effects of training dose was to train rats initially to a low dose of ethanol versus water and then retrain to a higher dose, or vice versa (Green and Grant, 1998) . Increasing the training dose increased the ED 50 of pentobarbital and dizocilpine, while eliminating the substitution of TFMPP, whereas lowering the training dose lowered the ED 50 of pentobarbital and dizocilpine and revealed substitution of TFMPP. This was taken as an evidence for an effect of training dose on overshadowing among the component elements of the ethanol cue (Green and Grant, 1998) . Overshadowing is said to occur if conditioning to a relatively weak stimulus is attenuated when it is always presented in combination with a more intense stimulus (Mackintosh, 1974) ; application of the concept in this area is based on the evidence for overshadowing of one drug by another in experiments, in which mixtures of dissimilar substances served as training stimuli (Mariathasan and Stolerman, 1993; White and Stolerman, 1996) . An interesting twist on the within-subject approach was to test the substitution of ethanol during different phases of the menstrual cycle in monkeys, to address the potential contribution of circulating progesterone on sensitivity to ethanol . Specifically, in the luteal phases in which progesterone is elevated, the ED 50 of ethanol substitution in lower phase compared with the follicular phase, in which progesterone is very low , but this effect held only for 1.0 g/kg of training dose of ethanol and not for a higher ethanol training dose or for the substitution pattern of midazolam (Green et al., 1997) . In summary, within-subject studies of ethanol training dose reflect the general findings of drug versus vehicle discriminations and further allow the investigation of learning or additive physiological factors in both qualitative and quantitative discriminative stimulus effects.
Gamma-aminobutyric acid mimetics Barbiturates
The barbiturate that has been most widely studied across training doses is pentobarbital, but limited evidence also exists for phenobarbital. Both rats (Overton, 1975 (Overton, , 1977 and gerbils (Järbe and Swedberg, 1998) consistently reached discrimination criteria in fewer sessions when trained on relatively high doses of pentobarbital. An exception was noted with the highest pentobarbital training dose in rats, a discrepancy probably attributable to the marked suppression of response rates (Ator and Griffiths, 1989 ). An assessment across phenobarbital training doses in rats revealed a similar inverse relationship between training dose and sessions to criteria (Fig. 2) . Greater discrimination accuracy was obtained with higher pentobarbital training doses, regardless of whether a 'drug versus no drug' procedure in parallel groups (De Vry and Slangen, 1986b; Järbe and Johansson, 1984) Ator and Griffiths, 1989 ). An additional 'drug versus drug' T-maze procedure in gerbils featured three training groups with low, medium or high pentobarbital doses discriminated from a fixed chlordiazepoxide dose (Järbe and Swedberg, 1998). Of note, the 5 and 15-mg/kg training doses of pentobarbital occasioned a high percentage of correct first-trial choices, whereas the medium dose (10 mg/kg) was indistinguishable from the chlordiazepoxide training dose. The three-lever procedures suggest that the qualitative characteristics of pentobarbital change as a function of training dose.
Benzodiazepines
The prototypical benzodiazepines used in studies examining training dose as an independent variable are chlordiazepoxide, diazepam, midazolam and lorazepam. Two stand-alone investigations provide preliminary insights into the role of training dose for the a 1 -subunitselective agonist alpidem (Sanger and Zivkovic, 1994) and the partial inverse agonist b-carboline-3-carboxylate ester (Rowlett et al., 1999) . Numerous studies demonstrated that benzodiazepine training dose magnitude was inversely proportional to the number of sessions to discrimination criteria in rats (Shannon and Herling, 1983; De Vry and Slangen, 1986b; Tang and Franklin, 1991; Sanger and Zivkovic, 1994; Rowlett et al., 1999; Bruner and Anderson, 2009 ) and gerbils (Järbe and Swedberg, 1998) . It is similarly well documented that lower benzodiazepine training doses are associated with a leftward shift in the dose-response curve (i.e., lower ED 50 ) when compared with higher doses of the same training drug in rats (Shannon and Herling, 1983; Slangen, 1986b, 1986b; Ator and Griffiths, 1989; Tang and Franklin, 1991; Sanger and Zivkovic, 1994; Ator, 1995a, 1995b; Rowlett et al., 1999; Bruner and Anderson, 2009 ) and humans (Rush et al., 1995) . When reported, maximal discrimination accuracy was found to be greatest for the higher benzodiazepine training doses (Shannon and Herling, 1983; De Vry and Slangen, 1986b; Bruner and Anderson, 2009 ).
Generalization of the barbiturate pentobarbital for chlordiazepoxide (De Vry and Slangen, 1986b ) and diazepam (Shannon and Herling, 1983; Tang and Franklin, 1991) was found at both low and high training doses, whereas pentobarbital only partially substituted for a low training dose of lorazepam while producing no highdose-appropriate responding (Ator and Griffiths, 1989) . This discrepancy may be explained by the relatively higher potency of lorazepam for the benzodiazepinebinding site. A few studies suggested that low training doses of chlordiazepoxide (Bruner and Anderson, 2009 ), midazolam (Sannerud and Ator, 1995a) and the partial inverse agonist b-carboline-3-carboxylate ester (Rowlett et al., 1999) are less selective because negative pharmacological controls (i.e., psychostimulants) were found to partially substitute for the low but not the high training doses. Additional evidence for qualitative differences across training-dose magnitude stems from antagonism tests. The partial agonist flumazenil (Ro-1788) partially substituted for a low chlordiazepoxide training dose, but was also demonstrated to block a high chlordiazepoxide training dose to a greater extent than a low one (De Vry and Slangen, 1986a) . A similar scenario was reported for the antagonist-like compound U-78875 and training doses of diazepam (Tang and Franklin, 1991) . In summary, the cue produced by high training doses of agonists and partial inverse agonists exhibits greater specificity for benzodiazepine receptors.
Gamma-hydroxybutyric acid
GHB is an endogenous ligand that acts through specific GHB receptors as well as GABA A and GABA B receptors after its metabolic conversion to GABA. Three studies established GHB discriminations in both rats and pigeons using food-reinforced T-maze and two-lever discrimination procedures, respectively. Higher training doses of GHB were associated with more rapid acquisition of discrimination criteria and rightward shifts in doseresponse curves (Colombo et al., 1995 (Colombo et al., , 1998 Koek et al., 2006) . It was also reported that the highest GHB training dose in pigeons achieved the greatest maximal discrimination accuracy (Koek et al., 2006) . Although GABA B receptor involvement persisted across training doses (as evidenced by both substitution with an agonist and blockade with an antagonist), partial substitution with diazepam-sensitive and diazepam-insensitive GABA A receptor agonists waned as the training dose increased (Colombo et al., 1998; Koek et al., 2006) . These findings suggest that the pharmacological specificity of GHB discrimination narrows with higher training doses. The antagonist NCS-382 completely blocked GHB-appropriate responding at two training doses in rats (Colombo et al., Training dose in drug discrimination Stolerman et al. 421 1995), whereas in pigeons NCS-382 failed to block either training dose and even partially substituted at low training doses (Koek et al., 2006) .
Nicotine
Studies in rats, mice and humans have examined the impact of varying the training dose of nicotine. Discrimination of higher doses of nicotine in rats was acquired more rapidly and remained more accurate than discrimination of low doses, indicating a quantitative effect related to training dose (Hirschhorn and Rosecrans, 1974; Chance et al., 1977; Stolerman et al., 1984; Gasior et al., 1999) . In most studies, ED 50 values also increased with training dose (Chance et al., 1977; Meltzer et al., 1980; Stolerman et al., 1984) . Figure 3 illustrates this relationship using ED 50 data for rats and mice from multiple publications. One study did not, at first, detect any differences between ED 50 values, but a difference was found when the dose-response curves were redetermined in the same animals (Gasior et al., 1999) . Possible qualitative differences in nicotine discrimination as a function of training dose have been explored to a limited extent. The nicotine antagonist, mecamylamine, was approximately equipotent in blocking discriminations maintained at two dose levels of nicotine in rats (Hirschhorn and Rosecrans, 1974) . Chance et al. (1977) found partial generalization to amphetamine at each of three nicotine training doses. Stolerman et al. (1984) observed more generalization to the nicotinic agonists, cytisine and anabasine, at a low training dose of nicotine, an observation that was attributed to primacy of actions of the low dose on high-affinity nicotinic receptor subtypes; there was no generalization at the low training dose to several non-nicotinic drugs, suggesting that specificity of the discrimination may not have been lost. Gasior et al. (1999) carried out tests with selective dopamine agonists and uptake inhibitors but did not find evidence for a qualitative change in nicotine discrimination.
The experiments discussed above used conventional, two-lever drug discrimination procedures. Murray and Bevins (2007) trained rats with different doses of nicotine as conditioned stimuli in a task requiring entries into a receptacle where sucrose solution was presented. The procedure appears functionally similar to one-lever operant conditioning techniques, although it was interpreted in Pavlovian terms as a goal-tracking experiment.
Rates of acquisition and ED 50 values for nicotine were similar at all training doses, but potential differences may have been obscured by unconditioned drug-induced changes in responding; one-lever operant discrimination procedures were abandoned long ago due to the confounding of discriminative and response rate effects.
Mice of the C57BL/6 strain acquired nicotine discrimination more rapidly at higher training doses (Stolerman et al., 1999 (Stolerman et al., , 2004 Shoaib et al., 2002) . Mecamylamine blocked nicotine discrimination at all three training doses (Stolerman et al., 1999) .
Human subjects are able to discriminate nicotine delivered by means of a nasal spray. Perkins et al. (1996) compared two training doses of nicotine and obtained results that were strikingly similar to the findings discussed above for animals.
Glutamate receptor ligands
The dissociative anaesthetics, phencyclidine and ketamine, are thought to act primarily through antagonism of NMDA glutamate receptors. Phencyclidine is the most widely studied drug of this class across training doses. The relevant studies all used a two-lever operant Rat and mouse ED 50 values from diverse studies showing the relationship with the training dose of nicotine. (a) Results from ten studies in Sprague-Dawley rats showing that training with lower doses of nicotine was associated with lower ED 50 values (*, data from Gasior et al., 1999; Mansbach et al., 2000; Young and Glennon, 2002; Bondarev et al., 2003; Desai et al., 2003; Batman et al., 2005; Le Foll and Goldberg, 2005; Young et al., 2006 ) and a within-study comparison of training doses in Lister-hooded rats (K, Stolerman et al., 1984) . (b) Results from Stolerman et al. (1999) showing the relationship of ED 50 values with training dose in C57BL/6 mice (K), and results at a single training dose for DBA/2 mice ('). This figure has been modified from a similar one in Smith and Stolerman (2009) with kind permission of Springer Science and Business Media.
conditioning procedure in rats with training of 'drug versus no drug' discriminations, unless otherwise noted. Phencyclidine discriminations met acquisition criteria more rapidly as a function of an increasing training dose (Beardsley et al., 1987; Beardsley and Balster, 1988; Jackson and Sanger, 1988) . A similar relationship was observed for both phencyclidine and ketamine training doses within a T-maze shock-escape procedure (Overton, 1975) . Leftward shifts in dose-response curves were demonstrated for low phencyclidine training doses compared with high ones (Beardsley et al., 1987; Beardsley and Balster, 1988; Jackson and Sanger, 1988) , and this shift in potency held regardless of whether comparisons were made between training dose groups or within the same group of pigeons that were serially retrained with progressively lower phencyclidine training doses (Fig. 4) . A heightened discriminative accuracy (or decline in percentage response error) for phencyclidine at high training doses compared with lower ones was reported in two studies (Beardsley et al., 1987; Mansbach and Balster, 1991) , whereas no difference was demonstrated in a third study with pigeons (Koek et al., 1987) .
The NMDA receptor antagonists, dizocilpine and AP-5, the s-agonist NANM, and the phencyclidine-derivative metaphit, all generalized regardless of phencyclidine training dose magnitude, and leftward shifts in the generalization curves were observed at lower training doses in rats (Jackson and Sanger, 1988) and pigeons (Koek et al., 1987) . In contrast, the competitive NMDA receptor antagonist CPP partially generalized to low and medium phencyclidine training doses (0.56 and 1.25 mg/kg), but not to the highest training dose studied (3.0 mg/kg; Mansbach and Balster, 1991) . Although no generalization to pentobarbital was observed for any training dose of phencyclidine in pigeons (Koek et al., 1987) , this barbiturate did fully substitute for the lowest, but no other, training dose of phencyclidine in rats (Mansbach and Balster, 1991) . Collectively, these findings suggest that high training doses of phencyclidine impart the greatest pharmacological specificity.
Although one study examined the role of training dose in the discrimination of the noncompetitive NMDA antagonist dizocilpine, limited testing was conducted and no discernable quantitative or qualitative characteristics were detected between training doses (Smith et al., 1999) .
Hallucinogens and other ligands for serotonin receptors
The impact of training dose on the discrimination of hallucinogens such as LSD was first studied by Cameron and Appel (1973) in rats, and most subsequent studies have also used rats. One group employed pigeons to investigate the 5-HT 1A agonist 8-hydroxy-(2-di-n-propylamino)-tetralin (8-OH-DPAT) that has been used extensively in studies of hallucinogenic and other drugs Leander, 1997, 1998) . Mice were also trained at different doses of LSD (Winter et al., 2005) , but there were no systematic comparisons across training doses.
Investigations in rats and humans have found that the dose-response curve for LSD shifts leftward at lower training doses, leading to reduced ED 50 values (Greenberg et al., 1975; Nielsen et al., 1982; Appel, 1982a, 1982b) . In some instances, the slope of dose-response curves was shallower at low training doses (e.g., Nielsen et al., 1982; White and Appel, 1982a) . Leftward shifts of the dose-response curve for 8-OH-DPAT have also been found after training with 8-OH-DPAT in pigeons (Wolff and Leander, 1997) and in tests of generalization from LSD to the 5-HT agonists quipazine, 8-OH-DPAT, and 5-OMeDMT in rats (White and Appel, 1982a; Young et al., 1983; Ybema et al., 1993 Ybema et al., , 1994 . After training with low doses of the 5-HT 1A partial agonist buspirone, leftward shifts of its dose-response curve were observed in rats (Ator, 1991) and humans (Rush et al., 1995) .
Qualitative features of the LSD stimulus also vary with training dose. Of note, the extent of generalization to quipazine and to 5-HT partial agonists increased at low training doses (White and Appel, 1982a) . Nielsen et al. (1982) showed that the full 5-HT 2 antagonists, pirenperone and ketanserin, blocked both high-dose and low-dose LSD cues, whereas the partial agonist, pizotifen, completely blocked only the low-dose cue, findings compatible with observations of and Colpaert and Janssen (1983) . However, White and Appel (1982a) found that the partial agonists, methiothepin and Training dose in drug discrimination Stolerman et al. 423 cyproheptadine, partially blocked all training doses of LSD. Further tests with 5-HT agonists and antagonists with predominantly peripherally acting 5-HT ligands suggested that peripheral actions of LSD may have contributed more to the low-dose cue (White and Appel, 1982a) . Pizotifen produced complete block of 5-OMeDMT when the discrimination was established at a small dose, but even a much larger dose did not block discrimination with a larger training dose; these and other data of Young et al. (1983 Young et al. ( , 1986 ) may perhaps be understood by taking account of the partial agonist properties of some of the substances used. The specificity of the LSD cue seems to be retained at low training doses, as determined from generalization tests with dopamine agonists and antagonists (White and Appel, 1982a) .
In an elegant application of drug versus drug discrimination methodology that yielded orderly and readily interpretable data, White and Appel (1982b) trained LSD versus lisuride, a dopamine agonist. Different groups of rats were trained with a fixed dose of LSD against one of three doses of lisuride. Apomorphine generalized fully with lisuride in all groups. Quipazine generalized with LSD, except when the training dose of lisuride was so large relative to that of LSD that the latter contributed little to the discrimination.
Cannabinoids
Studies have used between-subject and within-subject designs in rodents to examine quantitative differences in D 9 -tetrahydrocannabinol (THC) discrimination with training dose. Some reported smaller ED 50 values at lower doses, whereas others did not (Järbe et al., 1998 (Järbe et al., , 2006a (Järbe et al., , 2006b (Järbe et al., , 2010 . Anandamide does not substitute for THC at any training dose, yet anandamide analogues fully generalize and exhibit smaller ED 50 values at lower training doses (Järbe et al., 1998 (Järbe et al., , 2001 . CB1 antagonists block THC discrimination, and rimonabant may be more potent at lower training doses (Järbe et al., 2006a (Järbe et al., , 2010 . Overall, CP-55940 establishes the most potent CB1 cue, followed by THC, AM-1346 , and methanandamide (Järbe et al., 1998 , 2006b De Vry and Jentzsch, 2003) . Morphine does not substitute at any training dose yet (+)amphetamine partially generalizes with low doses (Järbe et al., 2006b (Järbe et al., , 1998 (Järbe et al., , 2009 ).
Together, the findings illustrate equivocal evidence for quantitative and qualitative differences in the stimulus effects of high and low THC training doses, yet reveal variation in the interoceptive effects of CB1 agonists.
Antidepressants Zhang and Barrett (1991) reported no difference in acquisition of imipramine discrimination between groups of pigeons trained at two doses, yet the low-dose group exhibited smaller ED 50 values. Overall, the high and low training doses did not differ qualitatively. Other tricyclic antidepressants generalized completely in both groups, although the low-dose group exhibited an enhanced sensitivity. Cocaine, amphetamine, nomifensine, tomoxetine and bupropion, but not a selective dopamine reuptake inhibitor, substituted for imipramine, suggesting some importance of both noradrenergic and dopaminergic mechanisms in the imipramine stimulus. Fluoxetine did not generalize, yet 5-HT 1A receptor agonists did, indicating that imipramine probably produces some effects similar to these compounds. Finally, scopolamine, a muscarinic antagonist, generalized with the high training dose of imipramine. Jones et al. (1980) reported that acquisition of bupropion discrimination was dose related; performance at the lower doses was unstable and differences in the bupropion stimulus as a function of training dose were not investigated further.
Antipsychotics
Dose-response curves for discriminative stimulus effects of the second-generation antipsychotic clozapine in rats were shifted leftward at low training doses (Goudie et al., 2004; Prus et al., 2004) . However, studies of the qualitative nature of the clozapine cue have yielded complex results. Low-dose clozapine discriminations generalized fully to the second-generation antipsychotics zotepine and melperone, but not to the first-generation antipsychotic haloperidol (Porter et al., 1999; Goudie et al., 2004; Prus et al., 2004) . The higher dose discrimination generalized fully to melperone, but not to zotepine or haloperidol. A low training dose of olanzapine showed no or full generalization to different first-generation antipsychotics, whereas a higher dose generalized fully to antipsychotics of both generations (Porter et al., 2000) . Studies of three-choice discriminations using two doses of clozapine and vehicle yielded different patterns of results (Prus et al., 2005 (Prus et al., , 2006 . The low training dose generalized fully to quetiapine and sertindole but not to other first-generation and second-generation antipsychotics, whereas the higher dose generalized fully to olanzapine but not to any other antipsychotic that was tested. Rather than reflecting antipsychotic actions, the discriminations may have been associated with actions on particular receptors; the anticholinergics scopolamine and trihexyphenidyl and the polyvalent antidepressant mianserin have also been found to generalize (inconsistently) with olanzapine and clozapine (Porter et al., 2000; Prus et al., 2004) . Thus, the training dose influences both quantitative and qualitative aspects of cues induced by some antipsychotic drugs, but a general rule relating to the nature of the qualitative changes cannot be discerned.
Conclusion

Quantitative aspects
Relationships between training dose and the rate of acquisition or magnitude of stimulus control have been found for diverse drugs. Typically, acquisition improves with dose up to a level above which drug-induced impairments of performance may have a deleterious impact. Most often, sensitivity, as measured by ED 50 values from dose-response determinations, increases when training dose is reduced. The mechanism of the change in sensitivity is commonly assumed to be a consequence of the training itself rather than of the different overall exposure to drug. Future research could attempt to distinguish such effects from those of training at varying doses, taking into account the larger numbers of training sessions that are sometimes needed with small training doses.
A small number of instances were identified where ED 50 values did not decrease with training dose. These include studies with opioid partial agonists, nicotine or cannabinoids. In some cases, training dose may not have been varied over a sufficiently wide range. In others, bias may have been introduced; poorly performing subjects are found with an increasing frequency as training dose declines and if they are excluded, effects of small training doses on ED 50 values and slopes of dose-response curves may be masked. Thus, subject selection may impact on the validity of conclusions about the relationship of sensitivity (ED 50 ) to training dose. It also seems inevitable that slopes will decline as the training dose approaches nondiscriminable levels, at which point druglever responding will be at chance levels and doseresponse curves will be flat. The ratio of the training dose to the ED 50 in the same animals is rarely presented but it may be an additional useful metric related to slope. In most investigations, subject selection is not an issue because the aim is to obtain subjects that perform well so that reliable data can be obtained during generalization tests with putative agonists and antagonists.
The reduced ED 50 at small training doses has implications for studies, in which different groups of subjects (e.g., different strains, sexes, genetically modified and wild-type animals) are compared for apparent sensitivity with the training drug. It is conceivable that real group differences may be masked; if one group is less sensitive to the training drug, the expected increase in ED 50 might be wiped out by an opposing decrease caused by training with the equivalent of a smaller dose. This is relevant to a study, in which sophisticated receptor mechanism explanations were put forward to explain negative results in a comparison of strains of rats that differed in several other procedures (Morgan et al., 1999) . In such cases, it seems necessary to use more than one training dose, so that the speed of acquisition, which consistently increases with training dose, can be taken as the metric.
Qualitative aspects
Numerous instances of variation in generalization profiles as a function of training dose have been reported for several species. However, there are many gaps in the evidence; for example, there are studies with rats and pigeons in which the training dose of an opioid is systematically varied but none with monkeys. Nevertheless, several general patterns have emerged from these reports. Firstly, subjects trained on full agonists often show greater generalization to partial agonists when the training dose is low and these effects are often accompanied by orderly findings for antagonism; drugs that substitute best for low training doses tend to attenuate the stimulus effects of high training doses. This pattern is seen with opioids and benzodiazepines and to some extent with LSD (i.e., in tests with full and partial 5-HT agonists). Secondly, there is a common tendency for specificity to be reduced at low training doses, for example, with opioid partial agonists and phencyclidine, although it is not universal. Subjects maintained on small training doses of phencyclidine generalized to CPP, as expected from their shared NMDA antagonist actions, but there was also generalization to a barbiturate, suggesting some loss of specificity. Evidence for reduced specificity at low training doses has not yet been obtained for cannabinoids and LSD, whereas the relative dearth of studies with antidepressants and antipsychotics precludes firm conclusions about them.
Another pattern that has been observed in some studies with low training doses of certain drugs is a decrease in generalization to agents of one class but an increase to those of another. Such findings imply shifts between the relative salience of stimulus elements originating at different classes of receptor. For example, when the training dose is low, ethanol generalizes to agents from several pharmacological classes (barbiturates, benzodiazepines, neuroactive steroids and some 5-HT agonists), but tests with other agents suggest that this is not due to a global loss of specificity. In contrast, large training doses of ethanol show an increased generalization to NMDA antagonists. A rather different pattern emerges with amphetamine; generalization to apomorphine appears to increase with training dose, whereas that to parahydroxyamphetamine decreases, the latter suggesting a shift from peripheral to central origins for the amphetamine cue, as may also be the case for the LSD cue. Curiously, data for generalization to para-hydroxyamphetamine at different training doses of cocaine do not seem to be available.
Summary
This review has identified many studies, in which the training dose influenced attributes of drug-produced discriminative stimuli. The quantitative changes are easier to explain and comprise increases in the rate of acquisition and robustness of stimulus control at large training doses, accompanied by reduced sensitivity, as shown by larger ED 50 values. Further insights may be obtained by more extensive investigations of druginduced stimuli built around the principles of signal detection theory, as applied to exteroceptive stimuli of different intensities, although altering the dose of a drug may influence not only the intensity of the stimulus that
Training dose in drug discrimination Stolerman et al. 425 it produces but may also affect its qualitative nature. This review has shown that qualitative changes as a function of training dose are complex and appear to fall into three categories: (a) changes in profiles of generalization between partial and full agonists, (b) reduced specificity of some discriminations at small training doses and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. It is also notable that three-lever discrimination procedures incorporating 'drug versus drug' or 'dose versus dose' contingencies enabled detection of more subtle differences than the simple 'drug versus no drug' approach when they were applied to the opioid, hallucinogen and barbiturate classes of drugs.
